Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for prostate cancer

W J Catalona

    Lancet (London, England)
    |June 4, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?

    Prostate cancer and prostatic diseases·2016
    Same author

    T rosette assay: in vitro correlate of cellular immunity.

    Urology·2011
    Same author

    Mutant L Homologue 1 (MLH1): a possible new immunohistochemical marker for prostatic cancer.

    Histopathology·2007
    Same author

    Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.

    Prostate cancer and prostatic diseases·2006
    Same author

    TGFBR1*6A is not associated with prostate cancer in men of European ancestry.

    Prostate cancer and prostatic diseases·2004
    Same author

    Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.

    Medical oncology (Northwood, London, England)·2004
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    Same journal

    Dual mobility total hip replacement in fractures: stability promotes patient confidence.

    Lancet (London, England)·2026
    Same journal

    Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

    Lancet (London, England)·2026
    See all related articles